Home / Stocks / VEEV

Veeva Systems (VEEV, Health Care Technology) Stock Valuation & Fair Value Poor on forward returns

Veeva Systems (VEEV, Health Care Technology) trades at a blended P/E of 30.9, about 49% below its historical normal valuation, with a forward growth estimate of 12.6% and a PEG of 2.46. Analysts' one-year estimates have been hit 18% of the time. Priced at its historical normal P/E of 60.0 on the same blended earnings, the 2026-10-02 close of $273.33 corresponds to about $531 a share. This is a valuation reference, not a price target.

DATA AS OF 2026-10-05
Blended P/E
30.9
Normal P/E
60.0
PEG
2.46
Fwd growth
12.6%
Div yield
0.0%
RSI (14)
62.8
Neutral
Technical context
  • Price $284.84 at the 2026-10-08 close, 4.2% above the 20-day average ($273.28) and 10.6% above the 50-day ($257.62).
  • RSI (14) at 62.8.
  • 52-week range $151.43 to $299.10: the price is 4.8% below the high and 88.1% above the low.

The Street vs SeerForecast

Wall Street's mean price target for VEEV is $297.30 across 27 analysts, 4.4% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: poor on forward returns. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been poor on forward returns since 2026-08-21.

Blended P/E and rating by weekBlended P/E moved from 29.1 to 30.9 between 2026-08-21 and 2026-10-02, against a normal P/E of 60.0, with 0 rating changes over 16 recorded weeks.2026-08-21: P/E 29.1, Poor on forward returns, recalculated for the week of 2026-08-212026-08-21: P/E 28.7, Poor on forward returns, recorded live 2026-08-242026-08-27: P/E 28.7, Poor on forward returns, recalculated for the week of 2026-08-272026-08-28: P/E 28.7, Poor on forward returns, recalculated for the week of 2026-08-282026-08-28: P/E 28.7, Poor on forward returns, recalculated for the week of 2026-08-302026-08-28: P/E 31.6, Poor on forward returns, recorded live 2026-08-312026-09-04: P/E 31.6, Poor on forward returns, recalculated for the week of 2026-09-052026-09-04: P/E 31.4, Poor on forward returns, recorded live 2026-09-072026-09-11: P/E 31.4, Poor on forward returns, recalculated for the week of 2026-09-122026-09-11: P/E 29.9, Poor on forward returns, recorded live 2026-09-142026-09-18: P/E 29.9, Poor on forward returns, recalculated for the week of 2026-09-192026-09-18: P/E 29.6, Poor on forward returns, recorded live 2026-09-212026-09-25: P/E 31.8, Poor on forward returns, recalculated for the week of 2026-09-262026-09-25: P/E 31.8, Poor on forward returns, recorded live 2026-09-282026-10-02: P/E 30.9, Poor on forward returns, recalculated for the week of 2026-10-032026-10-02: P/E 30.9, Poor on forward returns, recorded live 2026-10-0530.040.050.0Aug 21Aug 31Sep 11Sep 22Oct 2Normal P/E 60.0
Poor on forward returns

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-08-21P/E 29.1-52%Poor on forward returns (recalculated)
2026-08-24P/E 28.7-52%Poor on forward returns
2026-09-26P/E 31.8-47%Poor on forward returns (recalculated)
2026-10-05P/E 30.9-49%Poor on forward returns ← now
Show all 16 weeks
WeekBlended P/EPremium to normal P/ERating
2026-08-21P/E 29.1-52%Poor on forward returns (recalculated)
2026-08-24P/E 28.7-52%Poor on forward returns
2026-08-27P/E 28.7-52%Poor on forward returns (recalculated)
2026-08-28P/E 28.7-52%Poor on forward returns (recalculated)
2026-08-30P/E 28.7-52%Poor on forward returns (recalculated)
2026-08-31P/E 31.6-47%Poor on forward returns
2026-09-05P/E 31.6-47%Poor on forward returns (recalculated)
2026-09-07P/E 31.4-48%Poor on forward returns
2026-09-12P/E 31.4-48%Poor on forward returns (recalculated)
2026-09-14P/E 29.9-50%Poor on forward returns
2026-09-19P/E 29.9-50%Poor on forward returns (recalculated)
2026-09-21P/E 29.6-51%Poor on forward returns
2026-09-26P/E 31.8-47%Poor on forward returns (recalculated)
2026-09-28P/E 31.8-47%Poor on forward returns
2026-10-03P/E 30.9-49%Poor on forward returns (recalculated)
2026-10-05P/E 30.9-49%Poor on forward returns ← now

Frequently asked questions

Is Veeva Systems stock overvalued?

At a blended P/E of 30.9 versus its historical normal P/E of 60.0, Veeva Systems trades about 49% below its typical valuation, with a PEG of 2.46 on 12.6% forward growth. tickerseer currently rates it poor on forward returns.

What is Veeva Systems's fair value and PEG?

Veeva Systems trades at a blended P/E of 30.9 against a historical normal P/E of 60.0, a PEG of 2.46, and a forward growth estimate of 12.6%. Priced at its historical normal P/E of 60.0 on the same blended earnings, the 2026-10-02 close of $273.33 corresponds to about $531 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Veeva Systems changed?

tickerseer's rating has been poor on forward returns since 2026-08-21.

What is the analyst price target for Veeva Systems?

The mean Wall Street price target for Veeva Systems is $297.30 across 27 analysts, 4.4% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Technology. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track VEEV free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.